Last reviewed · How we verify
NCT07439913
Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer
trial testing Radical prostatectomy in Prostate Cancer (Adenocarcinoma) in 120 participants. Enrolling by invitation.
18 February 2026
Quick facts
| Lead sponsor | F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 1 February 2026 |
| Primary completion | 18 February 2026 |
| Estimated completion | 18 February 2026 |
| Sites | 1 location across Slovakia |
Drugs / interventions tested
- Radical prostatectomy
Conditions studied
- Prostate Cancer (Adenocarcinoma) — all drugs for Prostate Cancer (Adenocarcinoma) →
Sponsor
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica
Who can join
Eligibility, male only, with Prostate Cancer (Adenocarcinoma). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the present project is to evaluate long-term oncological and functional treatment outcomes, as well as patient satisfaction, ten years after radical prostatectomy in patients initially enrolled in CPRRP study. This research builds on a previous five-year follow-up evaluation (approved by the ethics committee) and focuses on the durability of therapeutic effects, quality of life, and long-term complications. Data will be collected via telephone interviews assessing key parameters (PSA levels, information on subsequent radiotherapy and androgen-deprivation therapy, the ICIQ-SF and IIEF-5 questionnaires, and patient-reported quality-of-life and satisfaction measures), followed by statistical analysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07439913
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Radical prostatectomy
Trials testing the same drug.
- NCT07490210 — Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer · Phase 2 · not yet recruiting
- NCT07163910 — Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinic · Phase 2 · recruiting
- NCT06844513 — Comparison Between HUGO RAS Robotic Platform and Da Vinci Robotic Platform · NA · not yet recruiting
- NCT06430411 — Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study · not yet recruiting
- NCT05513443 — Prostate Cancer IRE Study (PRIS) · NA · recruiting
Other recruiting trials for Prostate Cancer (Adenocarcinoma)
Currently open trials in the same condition.
- NCT07407608 — ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0 · recruiting
- NCT06957691 — Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Pro · Phase 2 · recruiting
- NCT07363382 — The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer · Phase 1, PHASE2 · recruiting
- NCT07302451 — REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients) · Phase 2 · active not recruiting
- NCT07115914 — PSMA PET for Surveillance After Focal Therapy · NA · recruiting
Other F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica trials
Trials by the same sponsor.
- NCT05156008 — Comparison of Ultrasound-guided and Palpation-inserted Peripheral Venous Cannula · NA · unknown
- NCT05486767 — Screening of Liver Fibrosis in Adults Without Known Liver Disease · unknown
- NCT04816682 — Silymarin in COVID-19 Patients Admitted to Hospital With Elevated Liver Enzymes · Phase 4 · completed
- NCT04758806 — Fecal Microbial Transplantation in Severe Alcoholic Hepatitis · Phase 3 · unknown
- NCT05261165 — Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07439913 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica
- Last refreshed: 27 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07439913.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing